What is in this article?:
- Q&A: Chinese Import of Corn Hybrids with the Agrisure Viptera Trait
- What can growers do?
What can growers do?
What should growers do if they have grain containing the Agrisure Viptera trait?
Many major grain handlers have notified Syngenta that they will accept grain with the Agrisure Viptera trait. They request that growers notify them upon delivery that their grain contains the trait.
Is there a number growers can call with questions?
Growers can call 800-319-1360 between 6 a.m. and 11 p.m. CST Monday through Saturday with questions, or email Syngenta at Export.Info@syngenta.com. Information can also be found online. Syngenta is working with the grain trade to discuss market options for grain with the Agrisure Viptera trait and will continue to develop customer communications.
When was the Agrisure Viptera trait commercialized?
2011 is the first year of commercialization for Syngenta’s Agrisure Viptera trait. Syngenta received deregulation from the USDA for the Agrisure Viptera trait in April 2010.
How many hybrids are involved?
Approximately 70 different hybrids contain the Agrisure Viptera trait, all ending in the hybrid designation of either 3110 or 3111.
Are any other Agrisuretraits affected by Chinese import restrictions?
No other commercially available Agrisure traits are affected.
Were corn hybrids with the Agrisure Viptera trait sold by GreenLeaf or any third parties in 2011?
The Agrisure Viptera trait was offered in a limited number of hybrids through GreenLeaf and third parties.
Will this affect sales of corn hybrids with the Agrisure Viptera trait?
Syngenta intends to sell corn hybrids with the Agrisure Viptera trait for next year and expects approval for the Agrisure Viptera trait in China by late March 2012.
Is this comparable to the StarLink situation?
Absolutely not. The Agrisure Viptera trait is fully approved for all uses in the U.S., including approval from the U.S. Food and Drug Administration. Also, the trait has approval in all of the key import markets for which the NCGA and BIO recommend before commercial launch.